This federal contract award is a Blanket Purchase Agreement (BPA) against the VA Schedule #V797P-7347A for reagents and consumables. The prime contractor is Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award was made by the Defense Health Agency, an agency within the U.S. Department of Defense, and has a ceiling value of $311,035.97...
This federal contract award to Roche Diagnostics Corporation is for the provision of reagents and consumables. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type and a ceiling value of $2,250,426.75. The award was made by the Defense Health Agency (DHA), a defense agency, with a period of performance ending on October 5, 2016. This contract does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro...
This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, with a ceiling value of $302,000.00, is a Blanket Purchase Agreement (BPA) Call placed by the Defense Health Agency (DHA) for the procurement of REAGENTS AND CONSUMABLES. This BPA is part of a larger Indefinite Delivery Contract vehicle held by Roche Diagnostics to provide chemistry reagents...
This is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $354,198.51 BPA is against the VA Schedule #V797P-7347A for reagents and consumables, with a firm fixed price and an ultimate completion date of May 2, 2025. The contract is not set aside and is part of Roche Diagnostics' broader portfolio of Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory equipment. The $2,800,000.00 Blanket Purchase Agreement (BPA) Call contract is for the provision of reagents and peripheral consumables. The contract is not designated as a set-aside. Roche Diagnostics holds multiple Indefinite Delivery Vehicles (IDVs) and BPAs with federal agencies such as...
This is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, valued at $379,486.57, is against VA Schedule #V797P-7347A for Reagents and Consumables and has a period of performance through September 24, 2024. No set-aside designation was used. Roche Diagnostics has provided critical care analyzers,...
This federal contract award is a Blanket Purchase Agreement (BPA) call placed by the Department of Veterans Affairs (VA) with Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The BPA, awarded under Roche's General Services Administration (GSA) Schedule contract, has a ceiling value of $49,526.94 and a performance period through December 17, 2022....
This federal contract award was made by the Department of Veterans Affairs to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $1,046,183.72, is a Blanket Purchase Agreement (BPA) call under Roche's General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The contract provides the VA with access to Roche's...
This is a Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract is against VA Schedule #V797P-7347A for reagents and consumables. The award has a ceiling value of $304,720.87 and a completion date of April 15, 2024. No set-aside was used. This BPA call is part of a larger $7 million BPA previously awarded to Roche Diagnostics by the VA to provide chemistry and...
The U.S. Defense Health Agency awarded Roche Diagnostics Corporation a Blanket Purchase Agreement (BPA) call valued at $2,515,000.00 for the provision of reagents and consumables. This is not a set-aside contract. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies, including the Department of Veterans Affairs, Department of...